Founders Capital Management (Texas)’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,093
Closed -$68.4K – 405
2025
Q2
$68.4K Sell
1,093
-598
-35% -$35.9K 0.04% 112
2025
Q1
$102K Buy
1,691
+1
+0.1% +$62 0.07% 78
2024
Q4
$98.6K Buy
1,690
+3
+0.2% +$178 0.06% 78
2024
Q3
$99.9K Buy
1,687
+2
+0.1% +$114 0.06% 81
2024
Q2
$94.4K Buy
1,685
+2
+0.1% +$112 0.06% 86
2024
Q1
$98.6K Sell
1,683
-41
-2% -$2.32K 0.07% 86
2023
Q4
$93.1K Buy
1,724
+7
+0.4% +$342 0.07% 84
2023
Q3
$83.3K Buy
1,717
+42
+3% +$2.23K 0.06% 89
2023
Q2
$94.6K Buy
1,675
+1
+0.1% +$55 0.07% 94
2023
Q1
$90K Buy
1,674
+1
+0.1% +$53 0.07% 94
2022
Q4
$88K Buy
1,673
+6
+0.4% +$304 0.07% 93
2022
Q3
$79K Hold
1,667
– – 0.06% 98
2022
Q2
$84K Buy
1,667
+2
+0.1% +$109 0.07% 94
2022
Q1
$110K Hold
1,665
– – 0.07% 87
2021
Q4
$110K Buy
1,665
+3
+0.2% +$192 0.07% 87
2021
Q3
$104K Hold
1,662
– – 0.07% 86
2021
Q2
$100K Hold
1,662
– – 0.07% 79
2021
Q1
$91K Hold
1,662
– – 0.06% 79
2020
Q4
$91K Buy
+1,662
New +$86.9K 0.06% 80
2020
Q1
$62K Buy
1,656
+300
+22% +$12.6K 0.06% 77
2019
Q4
$60K Buy
1,356
+600
+79% +$25.2K 0.05% 93
2019
Q3
$31K Hold
756
– – 0.02% 145
2019
Q2
$30K Hold
756
– – 0.03% 154
2019
Q1
$29K Hold
756
– – 0.03% 154
2018
Q4
$25K Buy
756
+156
+26% +$5.4K 0.03% 153
2018
Q3
$23K Hold
600
– – 0.02% 165
2018
Q2
$20K Hold
600
– – 0.02% 184
2018
Q1
$19K Hold
600
– – 0.02% 216
2017
Q4
$17K Hold
600
– – 0.01% 230
2017
Q3
$17K Hold
600
– – 0.01% 224
2017
Q2
$17K Hold
600
– – 0.02% 221
2017
Q1
$15K Buy
+600
New +$14.5K 0.01% 241

Other funds holding IHI

Founders Capital Management (Texas)'s IHI Position: Q3 2025 in Review

Founders Capital Management (Texas) sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 1,093 shares — an estimated $68.4K sold.

Founders Capital Management (Texas) first reported a position in IHI in Q1 2017 and held it in 32 quarters. The position peaked at $110K in Q1 2022. 526 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

  • Founders Capital Management (Texas) reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 1,093 iShares US Medical Devices ETF shares in Q3 2025, an estimated $68.4K.
  • Founders Capital Management (Texas) first reported a position in iShares US Medical Devices ETF in Q1 2017 and held it in 32 quarters.
  • Founders Capital Management (Texas)'s iShares US Medical Devices ETF position peaked at $110K in Q1 2022.
  • 526 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2025, filed 13 Nov 2025.